Market Eyes LiveTenet Healthcare Corporation New (THC) Stock Rating & Analysis
MELANY's data-driven read on Tenet Healthcare Corporation New · Services-General Medical & Surgical Hospitals, Nec.
Tenet Healthcare is a Dallas-based healthcare services company that operates acute and specialty hospitals (50 as of December 2025) along with hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, it also provides revenue cycle management solutions.
Why THC scores 71/100
MELANY scores Tenet Healthcare Corporation New 71/100 by weighing eight factors. Here is how THC breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- P/E 10.7x vs sector 22.0x median
- FCF yield 10.1%
Margins, returns on capital, and balance-sheet strength.
- Gross margin 42%
- ROE 37%
Direction and relative strength of the recent share-price trend.
- Price +25.0% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +21%
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for THC
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Tenet Healthcare Corporation New sits in the Healthcare sector theme, which MELANY currently rates 51/100 for strength. Theme strength feeds THC's momentum and catalyst factors above.
THC trade plan (members only)
MELANY has a full position plan for Tenet Healthcare Corporation New: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It unlocks free when you create an account.
How MELANY rates THC
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Tenet Healthcare Corporation New's 71/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about THC
Is Tenet Healthcare Corporation New (THC) a buy?
As of 2026-08-24, MELANY rated Tenet Healthcare Corporation New Highest Conviction with a composite score of 71/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Tenet Healthcare Corporation New's MELANY score?
Tenet Healthcare Corporation New (THC) has a MELANY composite score of 71/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the THC stock rating calculated?
MELANY scores THC from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Tenet Healthcare Corporation New stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Tenet Healthcare Corporation New (THC) Highest Conviction with a composite of 71/100 as of 2026-08-24. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the THC stock price forecast?
MELANY does not publish price targets or forecasts for THC. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 71/100 across eight factors for Tenet Healthcare Corporation New, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is THC stock overvalued or undervalued?
MELANY's valuation factor currently reads 69/100 for Tenet Healthcare Corporation New, where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives THC's read.
What price should I buy THC at?
Rather than chasing the current price, MELANY computes a smart entry zone for THC: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels unlock free when you create a Market Eyes Live account.
What are the risks of buying THC stock?
The top risks MELANY currently flags for Tenet Healthcare Corporation New: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Tenet Healthcare Corporation New a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 64/100 for Tenet Healthcare Corporation New, and earnings track record, at 100/100. The 71/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will THC stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 84/100 for THC right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this THC rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-24. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores THC continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
THC's entry zone, live alerts, and full trade plan are free either way. The app is our flagship.